563 related articles for article (PubMed ID: 23070002)
1. c-FLIP, a master anti-apoptotic regulator.
Safa AR
Exp Oncol; 2012 Oct; 34(3):176-84. PubMed ID: 23070002
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.
Safa AR; Pollok KE
Cancers (Basel); 2011 Jun; 3(2):1639-71. PubMed ID: 22348197
[TBL] [Abstract][Full Text] [Related]
3. Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.
Safa AR; Day TW; Wu CH
Curr Cancer Drug Targets; 2008 Feb; 8(1):37-46. PubMed ID: 18288942
[TBL] [Abstract][Full Text] [Related]
4. c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells.
Day TW; Huang S; Safa AR
Biochem Pharmacol; 2008 Dec; 76(12):1694-704. PubMed ID: 18840411
[TBL] [Abstract][Full Text] [Related]
5. Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy.
Safa AR
J Carcinog Mutagen; 2013; Suppl 6():. PubMed ID: 25379355
[TBL] [Abstract][Full Text] [Related]
6. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Le Clorennec C; Lazrek Y; Dubreuil O; Sampaio C; Larbouret C; Lanotte R; Poul MA; Barret JM; Prost JF; Pèlegrin A; Chardès T
Cell Commun Signal; 2019 Aug; 17(1):106. PubMed ID: 31443721
[TBL] [Abstract][Full Text] [Related]
7. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.
Jin TG; Kurakin A; Benhaga N; Abe K; Mohseni M; Sandra F; Song K; Kay BK; Khosravi-Far R
J Biol Chem; 2004 Dec; 279(53):55594-601. PubMed ID: 15485835
[TBL] [Abstract][Full Text] [Related]
8. The SCF
Roberts JZ; Holohan C; Sessler T; Fox J; Crawford N; Riley JS; Khawaja H; Majkut J; Evergren E; Humphreys LM; Ferris J; Higgins C; Espona-Fiedler M; Moynagh P; McDade SS; Longley DB
Cell Death Differ; 2020 Sep; 27(9):2726-2741. PubMed ID: 32313199
[TBL] [Abstract][Full Text] [Related]
9. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
Bellail AC; Tse MC; Song JH; Phuphanich S; Olson JJ; Sun SY; Hao C
J Cell Mol Med; 2010 Jun; 14(6A):1303-17. PubMed ID: 19432816
[TBL] [Abstract][Full Text] [Related]
10. c-FLIP: a key regulator of colorectal cancer cell death.
Wilson TR; McLaughlin KM; McEwan M; Sakai H; Rogers KM; Redmond KM; Johnston PG; Longley DB
Cancer Res; 2007 Jun; 67(12):5754-62. PubMed ID: 17575142
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
[TBL] [Abstract][Full Text] [Related]
12. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis.
Sharp DA; Lawrence DA; Ashkenazi A
J Biol Chem; 2005 May; 280(19):19401-9. PubMed ID: 15760909
[TBL] [Abstract][Full Text] [Related]
13. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway.
Yu W; Tiwary R; Li J; Park SK; Jia L; Xiong A; Simmons-Menchaca M; Sanders BG; Kline K
Mol Carcinog; 2010 Nov; 49(11):964-73. PubMed ID: 20886583
[TBL] [Abstract][Full Text] [Related]
14. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Song JH; Bellail A; Tse MC; Yong VW; Hao C
J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C
Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058
[TBL] [Abstract][Full Text] [Related]
16. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
[TBL] [Abstract][Full Text] [Related]
17. Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells.
Wang X; Chen W; Zeng W; Bai L; Tesfaigzi Y; Belinsky SA; Lin Y
Mol Cancer Ther; 2008 May; 7(5):1156-63. PubMed ID: 18483303
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers.
Nam SY; Jung GA; Hur GC; Chung HY; Kim WH; Seol DW; Lee BL
Cancer Sci; 2003 Dec; 94(12):1066-73. PubMed ID: 14662022
[TBL] [Abstract][Full Text] [Related]
19. ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.
Song JH; Kandasamy K; Kraft AS
J Biol Chem; 2008 Sep; 283(36):25003-13. PubMed ID: 18599488
[TBL] [Abstract][Full Text] [Related]
20. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.
Syed V; Mukherjee K; Godoy-Tundidor S; Ho SM
J Cell Biochem; 2007 Oct; 102(2):442-52. PubMed ID: 17393432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
